UB Paderborn / Katalog / Suche / in CDI

Randomized Phase 2 Study of Investigational, Selective Aurora a Kinase Inhibitor Alisertib (Mln8237) with Weekly Paclitaxel Vs Paclitaxel Alone in Patients (Pts) with Recurrent Ovarian Cancer (Oc)

Annals of oncology, 2014-09, Vol.25, p.iv305

2014

Volltextzugriff (PDF)

1308TiP - A phase I study of intraperitoneal MCY-M11 Anti-mesothelin CAR for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy

Annals of oncology, 2019-10, Vol.30, p.v531-v531

2019

Volltextzugriff (PDF)

A phase I study of intraperitoneal MCY-M11 Anti-mesothelin CAR for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy

Annals of oncology, 2019-10, Vol.30, p.v531

2019

Volltextzugriff (PDF)

367 Effects of alisertib (MLN8237), an investigational Aurora A kinase inhibitor (AAKi), on the QTc interval in patients (pts) with advanced malignancies

European journal of cancer (1990), 2015-09, Vol.51, p.S76-S77

2015

Volltextzugriff (PDF)

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2752-2760

1998

Volltextzugriff (PDF)

Trial in Progress: Phase 3 Randomized Study of Investigational Drug Alisertib (Mln8237) Vs Investigator'S Choice in Patients (Pts) with Relapsed/Refractory (Rel/Ref) Peripheral T-Cell Lymphoma (Ptcl): the Lumiere Trial

Annals of oncology, 2014-09, Vol.25, p.iv339

2014

Volltextzugriff (PDF)

Abstract PD5-5: Phase 2 study of single agent MLN8237 (alisertib), an investigational aurora A kinase (AAK) inhibitor, in patients (pts) with relapsed/refractory breast cancer (BrC)

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.PD5-5-PD5-5

2013

Volltextzugriff (PDF)

876ORANDOMIZED PHASE 2 STUDY OF INVESTIGATIONAL, SELECTIVE AURORA A KINASE INHIBITOR ALISERTIB (MLN8237) WITH WEEKLY PACLITAXEL VS PACLITAXEL ALONE IN PATIENTS (PTS) WITH RECURRENT OVARIAN CANCER (OC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv305-iv305

2014

Volltextzugriff (PDF)

1308TiPA phase I study of intraperitoneal MCY-M11 Anti-mesothelin CAR for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

985TiPTRIAL IN PROGRESS: PHASE 3 RANDOMIZED STUDY OF INVESTIGATIONAL DRUG ALISERTIB (MLN8237) VS INVESTIGATOR'S CHOICE IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (REL/REF) PERIPHERAL T-CELL LYMPHOMA (PTCL): THE LUMIERE TRIAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv339-iv339

2014

Volltextzugriff (PDF)

Synergistic Effects of IL-6 and IFN-γ on Carcinoembryonic Antigen (CEA) and HLA Expression by Human Colorectal Carcinoma Cells: Role for Endogenous IFN-β

Cytokine (Philadelphia, Pa.), 1995-02, Vol.7 (2), p.118-129

1995

Volltextzugriff (PDF)

Improved experimental radioimmunotherapy of colon xenografts by combining131I-CC49 and Interferon-γ

Diseases of the colon & rectum, 1994-02, Vol.37 (2), p.S100-S105

1994

Volltextzugriff (PDF)

Development and validation of prognostic models in metastatic breast cancer: a GOCS study

Oncology, 1992, Vol.49 (3), p.188

1992

Volltextzugriff (PDF)

Relation between delay and survival in 596 patients with breast cancer

Oncology, 1989, Vol.46 (2), p.78

1989

Volltextzugriff (PDF)

Distribution, DNA damage and cytotoxic effects of etoposide in human tumor xenografts in vivo

Anticancer research, 1991-07, Vol.11 (4), p.1379

1991

Volltextzugriff (PDF)

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

The New England journal of medicine, 2010-12, Vol.363 (25), p.2406-2415

2010

Volltextzugriff (PDF)

153. Improved antinimor efficacy of a radiolabeled monoclonal antibody when combined with interferon-gamma

Biomedicine & pharmacotherapy, 1992, Vol.46 (5), p.316-316

1992

Volltextzugriff (PDF)

Prevalence of Civilian Trauma and Posttraumatic Stress Disorder in a Representative National Sample of Women

Journal of consulting and clinical psychology, 1993-12, Vol.61 (6), p.984-991

1993

Volltextzugriff (PDF)

Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage

Arteriosclerosis, thrombosis, and vascular biology, 2001-10, Vol.21 (10), p.1662

2001

Volltextzugriff (PDF)

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-09, Vol.322 (9), p.824

2019

Volltextzugriff (PDF)

A population‐based study of therapy and survival for patients with head and neck cancer treated in the community

Cancer, 2012-09, Vol.118 (18), p.4452-4461

2012

Volltextzugriff (PDF)

Diabetes Induces Endothelial Dysfunction but Does Not Increase Neointimal Formation in High-Fat Diet Fed C57BL/6J Mice

Circulation research, 2005-06, Vol.96 (11), p.1178-1184

2005

Volltextzugriff (PDF)

Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib

The American heart journal, 2009-10, Vol.158 (4), p.513-519.e3

2009

Volltextzugriff (PDF)

Genetic background determines the extent of atherosclerosis in ApoE-deficient mice

Arteriosclerosis, thrombosis, and vascular biology, 1999-08, Vol.19 (8), p.1960

1999

Volltextzugriff (PDF)

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Journal of thoracic oncology, 2020-02, Vol.15 (2), p.274-287

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Randomized Phase 2 Study of Investigational, Selective Aurora a Kinase Inhibitor Alisertib (Mln8237) with Weekly Paclitaxel Vs Paclitaxel Alone in Patients (Pts) with Recurrent Ovarian Cancer (Oc)

1308TiP - A phase I study of intraperitoneal MCY-M11 Anti-mesothelin CAR for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy

A phase I study of intraperitoneal MCY-M11 Anti-mesothelin CAR for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy

367 Effects of alisertib (MLN8237), an investigational Aurora A kinase inhibitor (AAKi), on the QTc interval in patients (pts) with advanced malignancies

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer

Trial in Progress: Phase 3 Randomized Study of Investigational Drug Alisertib (Mln8237) Vs Investigator'S Choice in Patients (Pts) with Relapsed/Refractory (Rel/Ref) Peripheral T-Cell Lymphoma (Ptcl): the Lumiere Trial

Abstract PD5-5: Phase 2 study of single agent MLN8237 (alisertib), an investigational aurora A kinase (AAK) inhibitor, in patients (pts) with relapsed/refractory breast cancer (BrC)

876ORANDOMIZED PHASE 2 STUDY OF INVESTIGATIONAL, SELECTIVE AURORA A KINASE INHIBITOR ALISERTIB (MLN8237) WITH WEEKLY PACLITAXEL VS PACLITAXEL ALONE IN PATIENTS (PTS) WITH RECURRENT OVARIAN CANCER (OC)

1308TiPA phase I study of intraperitoneal MCY-M11 Anti-mesothelin CAR for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy

985TiPTRIAL IN PROGRESS: PHASE 3 RANDOMIZED STUDY OF INVESTIGATIONAL DRUG ALISERTIB (MLN8237) VS INVESTIGATOR'S CHOICE IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (REL/REF) PERIPHERAL T-CELL LYMPHOMA (PTCL): THE LUMIERE TRIAL

Synergistic Effects of IL-6 and IFN-γ on Carcinoembryonic Antigen (CEA) and HLA Expression by Human Colorectal Carcinoma Cells: Role for Endogenous IFN-β

Improved experimental radioimmunotherapy of colon xenografts by combining131I-CC49 and Interferon-γ

Development and validation of prognostic models in metastatic breast cancer: a GOCS study

Relation between delay and survival in 596 patients with breast cancer

Distribution, DNA damage and cytotoxic effects of etoposide in human tumor xenografts in vivo

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

153. Improved antinimor efficacy of a radiolabeled monoclonal antibody when combined with interferon-gamma

Prevalence of Civilian Trauma and Posttraumatic Stress Disorder in a Representative National Sample of Women

Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial

A population‐based study of therapy and survival for patients with head and neck cancer treated in the community

Diabetes Induces Endothelial Dysfunction but Does Not Increase Neointimal Formation in High-Fat Diet Fed C57BL/6J Mice

Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib

Genetic background determines the extent of atherosclerosis in ApoE-deficient mice

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Suchergebnisse filtern